Vitamin K reductase inhibitor
Apr 21, 2015
A Glimpse of the Anticoagulants Therapy Market; Major Players
VTE therapeutics & Atrial Fibrillation market was worth USD 4 billion in 2014 and USD 7.86 billion respectively. The VTE therapeutic market is expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29% and Atrial Fibrillation market will reach on its peak value USD 13.28 billi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
